GBIM on NASDAQ

GlobeImmune

Price unavailable

Last updated Oct 19, 2026.

Overview

Jan 1, 1995Founded¹

Compare with another stock.

TickerGBIM on NASDAQ¹
Industrybiotechnology¹
HeadquartersLouisville¹
Websitewww.globeimmune.com
Incorporated inDE⁴
Business address1450 Infinite Drive, Louisville, Co 80027⁴
Filer categorySmaller reporting company⁴

See how the biggest companies compare on our leaderboards

Labeled tarmogen MOA — Photo: CC-BY-SA-3.0, via Wikipedia⁵

GlobeImmune, Inc. is a clinical-stage public biopharmaceutical company headquartered in Louisville, Colorado, that develops therapeutic vaccines to treat cancer and infectious diseases. As of August 2014, the company had no marketed products. GlobeImmune’s therapeutic vaccines are developed on the company’s Tarmogen immunotherapy platform. Tarmogens are made from genetically modified yeast that express one or more disease-associated antigens. Tarmogens activate T cells to specifically target and eliminate diseased cells with the same target antigen.³

Leadership

Who has led GlobeImmune, and when. Pick a name to see everywhere that person has worked.

Chief executive

Timothy C. Rodell Jr.2014–2015

200020052010201520202025

Chief executive officerTimothy C. Rodell Jr. Jul 1, 2014 to Apr 10, 2015⁶

Board members and other officers (8)

VP, Finance, Treas & SecC. Jeffrey Dekker Jul 1, 2014 to Jan 8, 2015⁷
VP, Corporate DevelopmentKirk A. Christoffersen Jul 1, 2014 to Nov 4, 2015⁸
Board memberAugustine Lawlor Jul 1, 2014 to Mar 18, 2016⁹
Board memberDaniel J. Mitchell Jul 1, 2014 to Mar 18, 2016¹⁰
Board memberJ. William Freytag Jul 1, 2014 to Jul 13, 2015¹¹
Board memberPennina Safer Jul 1, 2014 to Dec 29, 2014¹²
Board memberS. Edward Torres Jul 1, 2014 to Mar 21, 2016¹³
Board memberTimothy C. Rodell Jr. Jul 1, 2014 to Apr 10, 2015⁶

Timeline

Jul 1, 2014New chief executive Timothy C. Rodell Jr. becomes CEO⁶
Jan 1, 1995Founded Founded¹

Sources

The numbers on this page point here. Each one links to the record it came from.

1
WikidataGlobeImmune on Wikidata
2
SEC EDGARGlobeImmune filings on SEC EDGAR
3
WikipediaGlobeImmune on Wikipedia
4
SEC EDGARGlobeImmune filings on SEC EDGAR
5
Wikimedia CommonsGlobeImmune photo by unknown, CC-BY-SA-3.0
6
SEC EDGARTimothy C. Rodell Jr., Chief executive officer
7
SEC EDGARC. Jeffrey Dekker, VP, Finance, Treas & Sec
8
SEC EDGARKirk A. Christoffersen, VP, Corporate Development
9
SEC EDGARAugustine Lawlor, Board member
10
SEC EDGARDaniel J. Mitchell, Board member
11
SEC EDGARJ. William Freytag, Board member
12
SEC EDGARPennina Safer, Board member
13
SEC EDGARS. Edward Torres, Board member

Overview

Leadership

Chief executive

Timeline

Links

Sources